{
    "root": "35570537-f855-4577-8a82-de357f115307",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "RYONCIL",
    "value": "20250311",
    "ingredients": [],
    "indications": "RYONCIL is indicated for the treatment of steroid refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older.",
    "contraindications": "For intravenous use only.",
    "warningsAndPrecautions": "RYONCIL is supplied as a sterile, cryopreserved cell suspension of ex-vivo culture-expanded allogeneic bone marrow-derived mesenchymal stromal cells (MSC) in vials.\n                  RYONCIL is provided as a customized kit to meet dosing requirements for a single dose for each patient [see Dosage and Administration (2.1)], with each kit containing:\n                  \n                     Cartons containing sufficient RYONCIL for one infusion based on the patient weight (see Table 5)\n                     Sufficient alcohol wipes for preparation of the RYONCIL infusions.\n                  \n                  Kit sizes and National Drug Codes (NDC) are provided in Table 5.\n                  \n                     Table 5: RYONCIL Kit Sizes\n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           Patient weight (kg)\n                           Kit contents (single infusion)\n                           Number of kits needed for:\n                        \n                        \n                           4-vial cartons\n                           1-vial cartons\n                           Total cartons\n                           Number of alcohol wipes\n                           NDC Number\n                           Initial course\n                           2nd course\n                           Relapse after CR\n                        \n                     \n                     \n                        \n                           <12.5\n                           0\n                           1\n                           1\n                           1\n                           73648-111-01\n                           8\n                           4\n                           8\n                        \n                        \n                           12.5-<25\n                           0\n                           2\n                           2\n                           2\n                           73648-112-02\n                        \n                        \n                           25-<37.5\n                           0\n                           3\n                           3\n                           3\n                           73648-113-03\n                        \n                        \n                           37.5-<50\n                           1\n                           0\n                           1\n                           4\n                           73648-114-01\n                        \n                        \n                           50-<62.5\n                           1\n                           1\n                           2\n                           5\n                           73648-115-02\n                        \n                        \n                           62.5-<75\n                           1\n                           2\n                           3\n                           6\n                           73648-116-03\n                        \n                        \n                           75-<87.5\n                           1\n                           3\n                           4\n                           7\n                           73648-117-04\n                        \n                        \n                           87.5-<100\n                           2\n                           0\n                           2\n                           8\n                           73648-118-02\n                        \n                     \n                  \n                  RYONCIL is shipped to the clinical facility in a liquid nitrogen dry shipper maintained at a temperature of ≤ -135°C.\n                  \n                     Storage conditions: RYONCIL must remain frozen at ≤ -135°C in liquid nitrogen vapor phase until thawed immediately prior to administration.\n                  \n                     Handling: Restrict preparation and administration of RYONCIL to a medical facility in which the medical personnel are trained in aseptic technique.\n                  \n                     Disposal: Dispose empty or partially used RYONCIL vials according to the institutional guidelines for disposal of biohazard materials.\n                  \n                     Do not save thawed RYONCIL vials for future use.",
    "adverseReactions": "Do not use RYONCIL in patients with known hypersensitivity to dimethyl sulfoxide (DMSO) or porcine and bovine proteins."
}